All
Support for Pediatric Inflammatory Bowel Disease Drug Developers in New FDA Draft Guidance
July 24th 2024While the document does not address treatment or prevention of the long-term complications of ulcerative colitis or Crohn’s disease in children, it aims to help sponsors developing drugs for pediatric patients currently affected.